ACLX
Price
$99.16
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
3 days until earnings call
SPRY
Price
$16.14
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
5 days until earnings call
Ad is loading...

ACLX vs SPRY

Header iconACLX vs SPRY Comparison
Open Charts ACLX vs SPRYBanner chart's image
Arcellx
Price$99.16
Change-$0.00 (-0.00%)
Volume$695.79K
CapitalizationN/A
ARS Pharmaceuticals
Price$16.14
Change-$0.00 (-0.00%)
Volume$588.44K
CapitalizationN/A
View a ticker or compare two or three
ACLX vs SPRY Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ACLX vs. SPRY commentary
Nov 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and SPRY is a Buy.

COMPARISON
Comparison
Nov 09, 2024
Stock price -- (ACLX: $99.16 vs. SPRY: $16.14)
Brand notoriety: ACLX and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 124% vs. SPRY: 63%
Market capitalization -- ACLX: $5.33B vs. SPRY: $1.52B
ACLX [@Biotechnology] is valued at $5.33B. SPRY’s [@Biotechnology] market capitalization is $1.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, both ACLX and SPRY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while SPRY’s TA Score has 4 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 4 bearish.
  • SPRY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ACLX and SPRY are a good buy in the short-term.

Price Growth

ACLX (@Biotechnology) experienced а +17.67% price change this week, while SPRY (@Biotechnology) price change was +9.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.66%. For the same industry, the average monthly price growth was +14.64%, and the average quarterly price growth was +11.72%.

Reported Earning Dates

ACLX is expected to report earnings on Mar 20, 2025.

SPRY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (+3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($5.57B) has a higher market cap than SPRY($1.65B). SPRY YTD gains are higher at: 194.526 vs. ACLX (78.667). ACLX has higher annual earnings (EBITDA): -46.86M vs. SPRY (-56.74M). ACLX has more cash in the bank: 517M vs. SPRY (219M). SPRY has less debt than ACLX: SPRY (160K) vs ACLX (74.3M). ACLX has higher revenues than SPRY: ACLX (145M) vs SPRY (500K).
ACLXSPRYACLX / SPRY
Capitalization5.57B1.65B337%
EBITDA-46.86M-56.74M83%
Gain YTD78.667194.52640%
P/E RatioN/AN/A-
Revenue145M500K29,000%
Total Cash517M219M236%
Total Debt74.3M160K46,438%
TECHNICAL ANALYSIS
Technical Analysis
ACLXSPRY
RSI
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
Declines
ODDS (%)
Bearish Trend 9 days ago
75%
Bearish Trend 15 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FEAMX16.170.14
+0.87%
First Eagle Rising Dividend Fund C
FMFCX97.190.36
+0.37%
Fidelity Advisor Materials C
EPLIX23.58-0.08
-0.34%
NYLI Epoch U.S. Equity Yield Inv Class
RSOOX40.94-0.16
-0.39%
Columbia Dividend Opportunity R
WIFMX3.69-0.03
-0.81%
Wasatch Frontier Emerg Sm Countrs Instl

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CRSP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
+6.65%
CRSP - ACLX
49%
Loosely correlated
+2.29%
BEAM - ACLX
47%
Loosely correlated
-1.99%
RCUS - ACLX
47%
Loosely correlated
+4.64%
RCKT - ACLX
46%
Loosely correlated
-1.88%
MGTX - ACLX
45%
Loosely correlated
+4.83%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
+2.67%
LPCN - SPRY
63%
Loosely correlated
-7.76%
INZY - SPRY
44%
Loosely correlated
-3.07%
ACLX - SPRY
42%
Loosely correlated
+6.65%
VIR - SPRY
39%
Loosely correlated
-3.93%
PLRX - SPRY
39%
Loosely correlated
-3.25%
More